About: European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria
Creator	Vanhems, Philippe De Waele, Jan Monnet, Dominique Friggeri, Arnaud Garnacho-Montero, José Gustin, Marie Jean, Astrid Kohlenberg, Anke Lepape, Alain Savey, Anne
Source	PMC
abstract	BACKGROUND: Antimicrobial resistance (AMR) compromises the treatment of patients with serious infections in intensive care units (ICUs), and intensive care physicians are increasingly facing patients with bacterial infections with limited or no adequate therapeutic options. A survey was conducted to assess the intensive care physicians’ perception of the AMR situation in the European Union/European Economic Area (EU/EEA). METHODS: Between May and July 2017, physicians working in European ICUs were invited to complete an online questionnaire hosted by the European Society of Intensive Care Medicine. The survey included 20 questions on hospital and ICU characteristics, frequency of infections with multidrug-resistant (MDR) bacteria and relevance of AMR in the respondent’s ICU, management of antimicrobial treatment as well as the use of last-line antibiotics in the six months preceding the survey. For the analysis of regional differences, EU/EEA countries were grouped into the four sub-regions of Eastern, Northern, Southern and Western Europe. RESULTS: Overall, 1062 responses from four European sub-regions were analysed. Infections with MDR bacteria in their ICU were rated as a major problem by 257 (24.2%), moderate problem by 360 (33.9%) and minor problem by 391 (36.8%) respondents. Third-generation cephalosporin-resistant Enterobacteriaceae were the most frequently encountered MDR bacteria followed by, in order of decreasing frequency, meticillin-resistant Staphylococcus aureus, carbapenem-resistant Enterobacteriaceae, carbapenem-resistant Pseudomonas aeruginosa and vancomycin-resistant enterococci. Perception of the relevance of the AMR problem and the frequency of specific MDR bacteria varied by European sub-region. Bacteria resistant to all or almost all available antibiotics were encountered by 132 (12.4%) respondents. Many physicians reported not having access to specific last-line antibiotics. CONCLUSIONS: The percentage of European ICU physicians perceiving AMR as a substantial problem in their ICU is high with variation by sub-region in line with epidemiological studies. The reports of bacteria resistant to almost all available antibiotics and the limited availability of last-line antibiotics in ICUs in the EU/EEA are of concern.
has issue date	2020-01-02(xsd:dateTime)
bibo:doi	10.1186/s13756-019-0662-8
bibo:pmid	31908772
has license	cc-by
sha1sum (hex)	5be75ae4e7f8c892abd8dc396b9dbd035772c84a
schema:url	https://doi.org/10.1186/s13756-019-0662-8
resource representing a document's title	European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria
has PubMed Central identifier	PMC6941296
has PubMed identifier	31908772
schema:publication	Antimicrob Resist Infect Control
resource representing a document's body	covid:5be75ae4e7f8c892abd8dc396b9dbd035772c84a#body_text
is schema:about of	named entity 'The' named entity 'management' named entity 'varied' named entity 'Intensive Care Medicine' named entity 'intensive care' named entity 'patients' named entity 'invited' named entity 'antibiotics' named entity 'high' named entity 'Bacteria' named entity 'problem' named entity 'The' named entity 'ICU' named entity 'resistant' named entity 'infections' named entity 'ALMOST ALL' named entity '360' named entity 'ONLINE' named entity 'INTENSIVE CARE UNITS' named entity 'Results' named entity 'Eastern' named entity 'reports' named entity 'intensive care units' named entity 'ICU' named entity 'Many' named entity 'moderate' named entity 'bacteria' named entity 'survey' named entity 'physicians' named entity 'problem' named entity 'bacteria' named entity 'Society' named entity 'antibiotics' named entity 'EEA' named entity 'Bacteria' named entity 'European' named entity 'physicians' named entity 'frequently' named entity 'MDR' named entity 'specific' named entity 'conducted' named entity 'European Economic Area' named entity 'respondents' named entity 'facing' named entity 'Infections' named entity 'Enterobacteriaceae' named entity 'ICUs' named entity 'meticillin' named entity 'epidemiological studies' named entity 'carbapenem' named entity 'antibiotics' named entity 'bacterial infections' named entity 'bacteria' named entity 'ICU' named entity 'ICUs' named entity 'carbapenem-resistant Enterobacteriaceae' named entity 'multidrug-resistant' named entity 'intensive care' named entity 'AMR' named entity 'assess' named entity 'regional' named entity 'tigecycline' named entity 'lastline' named entity 'diagnostic methods' named entity 'ICUs' named entity 'antibiotics' named entity 'ceftazidime' named entity 'European Centre for Disease Prevention and Control' named entity 'antibiotics' named entity 'Southern Europe' named entity 'bacteria' named entity 'antibiotics'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software